Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

October 13, 2014

Primary Completion Date

May 16, 2017

Study Completion Date

June 13, 2017

Conditions
Diabetic Macular Edema
Interventions
DRUG

Luminate 1.0mg

DRUG

Luminate 2.0mg

DRUG

Luminate 3.0mg

DRUG

Avastin

DRUG

Luminate 0.5mg

Trial Locations (17)

11967

Island Retina, Shirley

21205

Wilmer Eye Institute at John Hopkins University, Baltimore

28210

Charlotte EENT Associates, Charlotte

32503

Retina Specialty Institute, Pensacola

32701

Florida Eye Clinic, Altamonte Springs

33880

Center for Retina and Macular Disease, Winter Haven

49202

TLC Eye Group, Jackson

57701

Black Hills Regional Eye Institute, Rapid City

77098

Retina Consultant of Houston, Houston

78705

Austin Retina Associates, Austin

85020

Associated Retina Consultants, Phoenix

90211

Retina Vitreous Associates Medical Group, Beverly Hills

92705

Orange County Retina Medical Group, Santa Ana

94040

Northern California Retina Vitreous Associates, Mountain View

94109

West Coast Retina, San Francisco

99204

Spokane Eye Clinical Research, Spokane

06320

New England Retina Associates, New London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Trial Runners, LLC

OTHER

collaborator

Duke University

OTHER

lead

Allegro Ophthalmics, LLC

INDUSTRY